Novonix Raises A$20.7 Million to Boost Battery Material Production
Novonix has secured A$20.7 million from an institutional placement at a 33% discount, alongside a A$3 million Share Purchase Plan for existing shareholders, aiming to fund production capacity expansion amid growing battery demand.
- A$20.7 million raised via institutional placement at A$0.16 per share
- Share Purchase Plan launched to raise up to A$3 million at same discounted price
- Placement price reflects a 33% discount to last traded share price
- Funds targeted at capital expenditure to meet forecast customer demand
- ASX waivers sought to issue SPP shares at discount without shareholder approval
Institutional Placement Secures A$20.7 Million at Significant Discount
Battery materials specialist Novonix Limited (ASX:NVX, NASDAQ: NVX) has successfully raised approximately A$20.7 million through an institutional placement priced at A$0.16 per share. This price represents a steep 33.3% discount to the last traded price of A$0.24 on 15 June 2026 and a 31.2% discount to the five-day volume weighted average price (VWAP) of A$0.23. The placement was conducted under the company’s existing 15% placement capacity, reflecting a strategic move to quickly bolster capital for production growth.
Share Purchase Plan Offers Existing Shareholders Discounted Entry
In tandem with the placement, Novonix has launched a non-underwritten Share Purchase Plan (SPP) allowing eligible shareholders in Australia and New Zealand to acquire additional shares at the same discounted price of A$0.16. The SPP aims to raise approximately A$3.0 million if fully subscribed, with shareholders able to invest up to A$30,000 each free of brokerage fees. Notably, the company is seeking waivers from ASX Listing Rules to issue shares at a discount exceeding the usual 20% cap without shareholder approval, with shareholder approval as a fallback if waivers are not granted.
Capital to Support Production Capacity and Customer Demand
Novonix plans to deploy the proceeds from both the placement and SPP towards capital expenditure that will expand production capacity to meet forecast customer demand. Managing Director Mike O’Kronley emphasised that the capital raise is critical for executing the company’s growth strategy and reinforcing its ability to supply high-quality battery materials to strategic customers as demand intensifies. This aligns with the company’s recent milestones in synthetic graphite production and efforts to build a resilient North American supply chain.
Regulatory and Timing Considerations for the Placement and SPP
The institutional placement shares are expected to settle on 19 June 2026 and be allotted by 22 June 2026, coinciding with the opening of the SPP. The SPP will remain open until 14 August 2026 but may close early depending on waiver outcomes or shareholder approvals. Bell Potter Securities acted as lead manager for the placement, earning a 5% fee on funds raised. The new shares issued under both the placement and SPP will rank equally with existing shares from the date of issue.
Potential Dilution and Shareholder Approval Uncertainty
The discount offered in both the placement and SPP is substantial, which could weigh on the share price in the near term due to dilution concerns. The requirement for ASX waivers to issue SPP shares at this discount introduces an element of regulatory uncertainty, with the fallback being a shareholder meeting to approve the issue. How shareholders respond to this and the uptake of the SPP will be key factors to monitor as Novonix seeks to balance capital needs with shareholder interests.
Bottom Line?
Novonix’s latest capital raise underscores its commitment to scaling production capacity amid growing battery demand, but the steep discount and regulatory hurdles for the SPP inject caution around near-term dilution and shareholder sentiment.
Questions in the middle?
- Will Novonix secure ASX waivers to avoid shareholder approval for the SPP shares issuance?
- How will the market react to the significant discount on new shares and potential dilution?
- What is the anticipated timeline for the expanded production capacity funded by this raise?
